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Abstract
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Sensory and autonomic neurons of the peripheral nervous system (PNS) play a critical role in
regulating the immune system during tissue inflammation and host defense. Recent studies have
identified the molecular mechanisms underlying the bidirectional communication between the
nervous system and the immune system. Here, we highlight the studies that demonstrate the
importance of the neuro-immune interactions in health and disease. Nociceptor sensory neurons
detect immune mediators to produce pain, and release neuropeptides that act on the immune
system to regulate inflammation. In parallel, neural reflex circuits including the vagus nerve-based
inflammatory reflex are physiological regulators of inflammatory responses and cytokine
production. In transplantation, neuro-immune communication could significantly impact the
processes of host-pathogen defense, organ rejection, and wound healing. Emerging approaches to
target the PNS such as bioelectronics could be useful in improving the outcome of transplantation.
Therefore, understanding how the nervous system shapes the immune response could have
important therapeutic ramifications for transplantation medicine.

1. Introduction

Author Manuscript

The mammalian peripheral nervous system (PNS) coordinates the function and physiology
of major organ systems and barrier tissues. It is increasingly clear that the PNS also plays a
critical role in communicating with and regulating the function of the immune system.
Sensory neurons innervate joints, skin, muscles and the visceral organs, transmitting
information about thermal, mechanical, inflammatory, and noxious stimuli to brain, and are
an important component of the peripheral nervous system (1). Catecholamines and
acetylcholine released by sympathetic and vagus nerve fibers are important mediators of
many physiological functions including heart rate, urinary output, and gut motility. In
addition, neurotransmitters and neuropeptides interacting with cognate receptors expressed
on immune cells including neutrophils, macrophages, dendritic cells, T cells, B cells, and
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innate lymphoid cells regulate inflammation and cytokine production (2, 3). Recent studies
have advanced our understanding of peripheral neural pathways that regulate immune
responses in autoimmune and inflammatory conditions including arthritis, colitis, asthma,
endotoxemia and sepsis (2–4). Understanding this neuro-immune crosstalk in preclinical
models has important implications for the treatment of disease.
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Here we highlight studies elucidating bidirectional neuro-immune communication in health
and disease. During inflammation, nociceptor sensory neurons respond to immune cells and
their molecular mediators to signal pain; these neurons then release neuropeptides that
actively regulates immune cell function (Figure 1). In addition, neural reflex pathways
mediated by the afferent and efferent fibers in the vagus nerve, modulate innate and adaptive
immune responses in different visceral organ systems (Figure 2). Given the role of neural
reflex pathways in modulating immune responses in distal organs, it is likely that the
immune status of donor tissue during transplantation could be controlled by neural
pathways. The majority of donor organs are harvested from deceased donors, and are
associated with a number of immunological abnormalities. Furthermore, in transplantation
recipients, surgical or pharmacological perturbations may significantly alter PNS function.
The resulting changes in neuro-immune signaling could affect the outcome of wound
healing and inflammation. Targeting these neuro-immune pathways using vagus nerve
stimulation or pharmacological approaches may improve the outcome of transplantation.
2.1. Sensory Neuron-Immune Interactions in Pain and Inflammation
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Pain (Dolor) was defined as one of the four cardinal signs of inflammation by Celsus in 20
A.D. Pain is mediated by nociceptor sensory neurons, which detect noxious/harmful stimuli
to protect organisms from danger. Nociceptor neurons are pseudo-unipolar; their cell bodies
reside within the Dorsal Root Ganglia (DRG), while their axon is split into one peripheral
branch, which innervates the barrier tissues including the skin, lungs, gut, and one central
branch, which innervates the spinal cord to transmit noxious signals to the central nervous
system (CNS) to be processed as pain. The nerve terminals of nociceptors are equipped with
an array of molecular sensors, which detect heat, cold, protons, ATP, as well as receptors for
immune mediators including cytokines, lipid mediators, and growth factors.
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Immune cells play a critical role in mediating pain during inflammation. Pain
hypersensitivity occurs due to an increased responsiveness of nociceptor neurons to thermal
and mechanical stimuli. Several types of tissue-resident and infiltrating immune cells act in
concert to release cytokines and other mediators to sensitize nociceptor neurons (Figure 1A).
Upon degranulation, mast cells release TNF, IL-6, IL-1β, serotonin (5-HT), histamine, and
nerve growth factor (NGF) which act on pain fibers (5, 6). After nerve injury, mast cells
infiltrate the spinal cord and thalamus to sensitize CNS pain circuits (6). Tissue-resident
macrophages and circulating monocytes drive pain associated with incisional wound injury
and sciatic nerve injury (7, 8). Microglia, the resident innate immune cells of the CNS, also
critically mediate neuropathic pain (9–12). P38/ERK is activated in microglia following
nerve injury, leading to their release of prostaglandins and IL-1β within the spinal cord (9,
12). Inflammatory neutrophils contribute to pain by release of neutrophil elastase, which
activates protease activated receptor-2 (PAR2) on neurons (13). T cells also contribute to
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chronic pain by infiltrating the DRG and release of leukocyte elastase (14). The immune
contribution to pain may be sexually dimorphic: a recent study showed that T cells were
necessary for chronic neuropathic pain in female mice, whereas microglia but not T cells
drove chronic pain sensitization in male mice (11).
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To respond to the immune system, nociceptor neurons express a wide array of receptors for
cytokines, lipids, and growth factors (Figure 1A). For example, nociceptors express
receptors for the proinflammatory cytokines IL-1β, TNF, IL-6, and IL-17A, which play roles
in pain sensitization in rheumatoid arthritis and osteoarthritis. Nociceptors express G-protein
coupled receptors that respond to mast cell-derived histamine and serotonin (5-HT).
Prostaglandin E2 (PGE2) is also a critical mediator of pain by targeting EP1-EP4 on
neurons. Non-steroidal anti-inflammatory drugs (NSAIDs) act to inhibit cyclooxygenase
mediated production of PGE2. Nociceptors also express TrkA, which recognizes nerve
growth factor (NGF) released by macrophages and mast cells during inflammation. In
addition to responding to immune-derived mediators, nociceptor neurons are also able to
respond to pathogens and their molecular mediators including N-formyl peptides, the toxin
α-hemolysin, and TLR ligands (15, 16) (Figure 1A). Neuronal signaling through cytokine
and growth factor receptors leads to calcium influx, cAMP induction, as well as kinase
signaling pathways through PKC, PLCγ and MAP Kinases, which converge to induce
changes in neuronal membrane properties and the gating of nociceptive ion channels (Figure
1A). Nav1.7, Nav1.8, and Nav1.9 are voltage-gated sodium channels that play a critical role
in generation of action potentials in nociceptors; congenital mutations in these channels are
linked to human insensitivity to pain. Transient Receptor Potential (TRP) channels including
TRPV1, TRPA1, TRPV4, mediate the sensation of noxious thermal and mechanical stimuli
(1, 17). Immune-mediated signaling within nociceptor neurons lead to phosphorylation of
TRP channels and voltage-gated sodium channels to decrease their threshold for activation,
thus potentiating pain hypersensitivity. Therefore, nociceptor neurons are exquisitely tuned
to respond to the immune system to produce pain.
2.2. Nociceptor Sensory Neuron Regulation of the Immune Response
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Nociceptor neurons also play an important role modulating the function of immune cells
(Figure 1B). The neuropeptides substance P (SP), calcitonin gene-related peptide (CGRP),
and vasoactive intestinal peptide (VIP) are small, positively charged peptides stored within
dense-core vesicles at nociceptor nerve terminals. During pain production, local axonal
reflexes and calcium influx into peripheral nerve terminals leads to SNARE-mediated
vesicular fusion and release of neuropeptides which have potent effects on the vasculature
and immune system, a process termed “neurogenic inflammation”. SP and CGRP act on
smooth muscle cells and endothelial cells to produce edema and vasodilation, respectively.
Recent work has shown that SP, CGRP, and VIP have potent effects on the immune response
by binding their cognate receptors on macrophages, dendritic cells, T cells and innate
lymphoid cells to regulate their function (Figure 1B). Nociceptor neurons play an important
role in host defense against pathogens. In skin infection by the bacterial pathogen
Staphylococcus aureus, nociceptor neurons suppressed the infiltration of myeloid immune
cells into infected skin and draining lymph node immune cell recruitment (16). By contrast,

Am J Transplant. Author manuscript; available in PMC 2019 March 01.

Chavan et al.

Page 4

Author Manuscript

in skin infections caused by the fungal pathogen Candida albicans, nociceptors drove
dendritic cell activation and expression of IL-23 to mediate host protection (18). The
differential effects observed may be due to the type of nociceptor neurons and immune cells
involved. For example, the epidermal and dermal layers are innervated by many types of
sensory fibers, including peptidergic and nonpeptidergic nociceptors. Each of these
nociceptor subsets could be interacting differentially with distinct innate or adaptive immune
cells to mediate either immune activation or suppression depending on the type of
pathogenic stimulus. Given the importance of preventing infections during and after organ
transplantation, the role of nociceptor neurons and modulation of pain could aberrantly
affect the outcome of infection.
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Nociceptor neurons also play direct roles in driving inflammatory diseases of the respiratory
tract, skin, and gut. In mouse models of asthma, nociceptor neurons drive
bronchoconstriction, airway hyperreactivity, and type 2 immune cell responses (19–21).
Neurons have been found to release VIP in the lungs, which acts on type 2 innate lymphoid
cells (ILC2) to recruit downstream T cell and eosinophil responses to drive antigen-specific
allergic responses (19). Nociceptor neurons have also been found to drive inflammation in a
mouse model of psoriasis; nociceptors interact with Dendritic cells to induce their
production of IL-23, that in turn drives IL-17A production and skin pathology (22). In
mouse models of colitis, the nociceptive ion channel TRPA1 and neuropeptide SP drive
cytokine production and tissue inflammation (23). By contrast, the cold-sensing ion channel
TRPM8 and the nociceptive neuropeptide CGRP downmodulates colitis-associated
inflammation (24). Therefore, nociceptor neurons actively communicate with immune cells
through neuropeptides to play potent roles in host defense and inflammation.
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3.1. Neural reflex regulation of inflammation
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Advances in the immunological and neurophysiological techniques have facilitated the
studies of neural reflex circuits that regulate inflammatory responses. A typical neural reflex
circuit is comprised of sensory neurons that transmit information about peripheral changes
to the interneurons in the CNS, and motor neurons which in turn relay efferent signals to the
peripheral tissues. The inflammatory reflex is the prototypical neural circuit comprised of
afferent and efferent signals in the vagus nerve that regulate the output of the innate immune
system (2, 25, 26). Within the immune system, lymphoid organs including thymus, lymph
nodes, liver and spleen are richly innervated by a peripheral neural network that transmits
information to and from the CNS in response to infection or sterile injury, and modulate
inflammatory responses. Peripheral inflammatory signals play an important role in
regulating host defense responses orchestrated by the CNS. Pioneering work by the Watkins
group in the 1990s have mapped how the intact vagus nerve is required for a fever response
to low doses of intraperitoneal IL-1β, suggesting that vagus sensory fibers are important to
detect and transmit the information about peripheral immune responses to CNS (27, 28).
Afferent vagus nerve signals are also implicated in mediating the sickness syndrome,
associated with febrile response, social withdrawal, lethargy and other symptoms, in
response to peripheral inflammatory challenges (29, 30). Vagal sensory neurons are activated
in response to infectious challenges and inflammatory mediators via pattern recognition
receptors or cytokine receptors expressed on these sensory neurons or on the chemosensory
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cells in the associated vagal paraganglia (30–32). Furthermore, in addition to inducing
afferent vagus nerve activity, peripheral increases in IL-1β induce increased splenic nerve
activity (33–35). Together, these studies opened up an important question of whether
inflammatory mediators lead to an activation of a selective neural ensemble within the vagus
nerve. Using electrophysiogical recordings, a recent study demonstrated that inflammatory
cytokines (IL-1β and TNF), induce discriminating patterns of afferent vagus nerve activity
or “neurograms” (36). This cytokine-specific activity is absent in animals with genetic
ablation of the IL-1β or TNF receptors. Furthermore, selective vagus transection distal to the
recording electrodes ablates the signals, indicating that majority of the signals are associated
with afferent vagus fibers (36). These studies indicate that afferent vagus nerve fibers
mediates the sensory arc of the inflammatory reflex, where it senses perturbations in
peripheral immune homeostasis and transmits the information to the CNS in a mediatorspecific manner.
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The discovery of the motor arc of the inflammatory reflex occurred during studies focused
on delineating the anti-inflammatory mechanisms of CNI-1493, a tetravalent
guanylhydrazone. CNI-1493 (Cytokine Network Incorporation-1493) was originally
described as an inhibitor of macrophage activation, carrageenan-induced inflammation and
endotoxin-induced lethality (37). CNI-1493 suppressed cytokine release by inhibiting
phosphorylation of p38 mitogen activated protein kinase (37–39). During the course of
studying the activity of CNI1493 in cerebral ischemia, it was observed that intracerebral
administration of low quantities of CNI-1493 not only inhibited inflammatory responses in
the brain but also in peripheral organs including spleen, liver and heart (40). This was a
surprising result as the quantities administered in the brain were less than required to
suppress macrophages in vitro. By selectively cutting the vagus nerve, it was then possible to
isolate signals from the brain to the periphery, and show that an intact vagus nerve was
required for cytokine inhibition in the periphery. These results indicated that signals
descending from the brain stem, and transmitted in the vagus nerve regulated inflammatory
responses in the visceral organs (Figure 2). Efferent signals traveling in the vagus nerve
terminate in the celiac ganglia (41, 42), and activate adrenergic splenic nerve, which
originate from the celiac ganglia. Norepinephrine released by splenic neurons induces
acetylcholine release by a small subset of splenic T cells that express choline
acetyltransferase (ChAT), a rate-limiting enzyme in the acetylcholine biosynthesis (43, 44).
Nude mice deficient in T cells fail to respond to suppressive effects of the vagus nerve
stimulation, and adoptive transfer of ChAT-expressing T cells into nude mice restores the
anti-inflammatory effect, indicating that ChAT-expressing T cells are necessary for the
integrity of the inflammatory reflex (44). Acetylcholine released by these splenic T cells
under vagus nerve control binds to α7 nicotinic acetylcholine receptor (α7nAChR) on
macrophages (44, 45) and suppresses cytokine production via activation of a JAK2/STAT3
pathway, suppression of NF-kB nuclear translocation, and attenuation of inflammasome
activation (2, 46–48). Subsequent studies have established the anti-inflammatory and
disease-alleviating function of vagus nerve signaling in a number of preclinical disease
models including endotoxemia (42), sepsis (49), arthritis (50), pancreatitis (51), ischemia
reperfusion and injury (52, 53), inflammatory bowel disease (54), post-operative ileus (55),
hemorrhagic shock (47), and autoimmune myocarditis (56).
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These preclinical studies have paved the way to clinical exploration of neuromodulation
modalities using bioelectronic devices. Bioelectronic medicine is an emerging field that
focuses on targeting neural networks that regulate molecular mechanisms of disease, and
using bioelectronic devices to modulate these neural networks as a treatment strategy. Two
recent clinical studies demonstrated efficacy of electrical stimulation of the inflammatory
reflex in attenuating disease severity in inflammatory and autoimmune diseases (57, 58).
Rheumatoid arthritis is a disabling chronic autoimmune disease characterized by synovial
inflammation and painful swollen joints. Stimulation of the inflammatory reflex using
implanted bioelectronic devices in rheumatoid arthritis patients inhibited cytokine
production and attenuated disease severity (58). Withdrawal of the vagus nerve stimulation
exacerbated the disease, and reinstating the stimulation treatment restored the protective
effect. Another clinical study reported significant benefit of vagus nerve stimulation using
implanted devices in Crohn’s disease patients (57). Crohn’s disease is a debilitating chronic
inflammatory disease of the bowel, and affects mainly young adults. Chronic vagus nerve
stimulation for six months offered significant clinical, biological and endoscopic remission
in five out of seven patients. These beneficial effects were associated with restoration of
vagus nerve activity as assessed by heart rate variability (57).
3.2. Neural Reflex Regulation of Transplantation
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In transplantation medicine, inflammatory reactions in the graft have a pivotal influence on
acute as well as long-term function of the transplanted graft. The inflammatory responses in
the donor organs are principally mediated by ischemia/reperfusion injury in the donor organ,
infection, and rejection episodes in the recipient. Currently, majority of the organs for
transplantation are acquired from brain-dead donors; however, the presence of brain death is
an important risk factor that dictates the graft function. As the demand for organ
transplantation continues to grow, a major challenge in the transplantation medicine is to
increase graft acceptance and function in chronic condition. Using pharmacological
interventions, Yeboah and colleagues (59) have demonstrated that cholinergic agonists
attenuate renal ischemia and reperfusion injury in experimental models. In a series of studies
using preclinical models of acute and chronic renal transplantation, Hoeger and colleagues
(60, 61) noted that vagus nerve stimulation in brain dead donors improves both acute and
long-term graft function in the recipients after transplantation. These studies suggest that
activation of the inflammatory reflex via vagus nerve stimulation in brain dead donors
improves ischemia reperfusion mediated renal graft injury, and paves a way to improve graft
function in the recipient. A very recent study provided an important mechanistic insight into
the mechanisms underlying the protective effects of vagus nerve stimulation in attenuating
ischemia and reperfusion injury (53). Ischemia reperfusion injury is a critical determinant of
the graft function in transplantation. Vagus nerve stimulation prior to renal ischemia and
reperfusion significantly attenuated acute kidney injury and decreased plasma TNF. Genetic
ablation of α7nAChR abrogated this protective effect. Furthermore, splenectomy abolishes
the effects of vagus nerve stimulation that can be restored by adoptive transfer of
splenocytes obtained from vagus nerve stimulated animals. These observations indicate that
α7nAChR-positive splenocytes play an important role in mediating vagus nerve induced
attenuation of kidney injury during ischemia reperfusion. Together, these results suggest that
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bioelectronic devices for modulation of neural circuitries can be an efficient alternative of
drug treatments in the transplantation medicine.

4. Implications for Transplantation Medicine
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Neuro-immune interactions could play an important role in clinical settings of
transplantation. Organ transplantation and surgery could lead to changes in the peripheral
neural circuits that disrupts or aberrantly activates sensory or autonomic neuron
communication with immune cells. Pharmacological interventions could also directly affect
these neuro-immune interactions. For example, opioids, NSAIDs and other analgesics are
often given to treat pain during surgery and for post-surgical care. Given the role of
nociceptor neurons in modulating innate and adaptive immune cell function, alterations in
pain signaling could adversely affect normal inflammatory processes required for wound
healing. Similarly, pharmacological agonists or antagonists of sympathetic and
parasympathetic neurons could affect immune responses and transplant rejection.
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Targeted modulation of neuro-immune interactions to treat inflammation could be an
exciting way to improve inflammatory outcomes during and after transplantation. Vagus
nerve stimulation, currently applied in treatment of rheumatoid arthritis and inflammatory
bowel disease, could be an interesting approach to modulate the immune response in organ
transplantation. Implantable bioelectronics devices that work on specific branches of the
vagus nerve could further target this immunomodulation to distinct organ systems. In
addition to electrical stimulation of the inflammatory reflex, pharmacological interventions,
such as α7nAChR or β2 adrenoreceptor agonists to activate the inflammatory reflex have
been explored in preclinical settings. Future advances in the field of neuro-immunology in
genetic targeting, electronic stimulation of neural circuits, and pharmacological modulation
of the communication between the nervous and immune system could lead to new
approaches to modulate the immune response and improve the outcomes of transplantation.
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PNS

Peripheral nervous system

DRG

Dorsal root ganglia

Ach

Acetylcholine

NE

Norepinephrine

CNS

Central nervous system

SP

Substance P

CGRP

calcitonin gene-related peptide
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VIP

Vasoactive intestinal peptide

NGF

Nerve Growth Factor

PGE2

Prostaglandin E2

TRP

Transient Receptor Potential

α7nAChR

α7 nicotinic acetylcholine receptor

ChAT

choline acetyltransferase
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Figure 1. Nociceptor Sensory Neurons Crosstalk with Immune Cells in Pain and Inflammation
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(a) Nociceptor neurons are activated by immune cells and their molecular mediators.
Pathogens, tissue injury, and other inflammatory insults trigger a immune response. These
immune cells including neutrophils, mast cells, macrophages and T cells release molecular
mediators including pro-inflammatory cytokines, nerve growth factor (NGF), prostaglandin
E2 (PGE2), serotonin and histamine. Nociceptor sensory neurons express receptors for these
immune-derived mediators, including cytokine receptors, G-protein coupled receptors, and
tyrosine kinase receptor type 1 (TrkA). Sensory neurons also express pathogen recognition
receptors including FPR1, and toll-like receptors (TLRs). The bacterial toxin α-hemolysin
also forms pores in neuronal membranes to directly activate neurons. Upon ligand binding,
generation of second messenger signaling through cAMP or Ca2+ can lead to intracellular
phosphorylation cascades that produce changes in the gating properties of TRPV1, TRPA1
cation channels and the voltage-gated sodium channels Nav1.7, Nav1.8, and Nav1.9. These
ion channels are critical for pain production, and their sensitization during inflammation
leads to increased action potential generation, neuronal plasticity, and transcriptional
changes in nociceptor neurons that results in pain. (b) Nociceptor neurons play an important
role in regulating immune cell function by communication with them through neuropeptides.
In peripheral nerve terminals, neuropeptides including substance P, calcitonin gene-related
peptide (CGRP), and vasoactive intestinal peptide (VIP) are stored in dense-core vesicles.
During inflammation, generation of action potentials, local axonal reflexes, and Ca2+ entry
into these terminals leads to SNARE-mediated vesicle release of these neuropeptides. These

Am J Transplant. Author manuscript; available in PMC 2019 March 01.

Chavan et al.

Page 13

Author Manuscript

neuropeptides then regulate tissue inflammation by activating receptors present on smooth
muscle cells, endothelial cells, macrophages, dendritic cells and innate lymphoid cells
(ILCs). These neuro-immune interactions mediate host-pathogen responses, asthma,
inflammatory bowel disease, arthritis, and other inflammatory disease conditions.
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Figure 2. Vagal Efferent Anatomy and the Cholinergic Anti-inflammatory Reflex
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Visceral organs in the thoracic and abdominal cavity including the lungs, heart, liver,
stomach, gut, pancreas and kidneys are innervated by parasympathetic and sympathetic
nerves. The efferent portion of the vagus nerve, which is the preganglionic parasympathetic
fiber, originates from the dorsal motor nucleus (DMN) and nucleus ambiguous (NA) in the
medulla oblongata and project to postganglionic fibers in proximity with or within visceral
organs. Both the preganglionic and postganglionic vagal fibers are cholinergic.
Postganglionic vagal fibers release acetylcholine (Ach) into viscerl organs to regulate
smooth muscle activity, gut motility, and gland secretion. In the spinal cord, sympathetic
neurons received descending projects from the locus coeruleus (LC) and the
rostroventrolateral medulla (RMLM) in the brainstem. The sympathetic preganglionic fibers
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interact with postganglionic fibers within the paravertebral and prevertebral ganglia.
Postganglionic fibers from paravertebral and prevertebral ganglia innervate visceral organs
in the thorax (lungs, heart) and the abdominal cavity (liver, stomach, gut, kidneys, pancreas)
respectively, and release norepinephrine (NE). Sympathetic preganglionic fibers also
innervate the adrenal medulla directly and stimulate the secretion of epinephrine (EP) from
chromaffin cells. Both vagal and sympathetic preganglionic fibers give projections to the
splenic nerve within the celiac and superior mesenteric ganglion. In a cholinergic antiinflammatory reflex, NE released by the splenic nerve acts on choline acetyltransferase
(ChAT)+ CD4+ T cells through β2-adrenergic receptors. These T cells release Ach to
regulate macrophage production of TNF-α and other cytokines.
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